busulfan,treosulfan
medexus,otsuka,medac
['treosulfan', 'busulfan']
 absolutely is an important consideration. relatively small sample size, but in 70 dba pts who received allo bmt for dba had no secondary malignancy after busulfan or treosulfan. 10.1182/bloodadvances.2019001210
Pediatric hematology/oncology | Stem cell biology | AML | Gene therapy | CRISPR